216 related articles for article (PubMed ID: 9373050)
1. Antihypertensive and renal effects of isradipine in essential hypertension: focus on renin system activity.
Allikmets K; Parik T; Teesalu R
Angiology; 1997 Nov; 48(11):977-83. PubMed ID: 9373050
[TBL] [Abstract][Full Text] [Related]
2. Acute and chronic effects of spirapril, alone or in combination with isradipine on kidney function and blood pressure in patients with reduced kidney function and hypertension.
Shohat J; Wittenberg C; Erman A; Rosenfeld J; Boner G
Scand J Urol Nephrol; 1999 Feb; 33(1):57-62. PubMed ID: 10100366
[TBL] [Abstract][Full Text] [Related]
3. [Renin aldosterone profile in essential hypertension during pregnancy and after delivery].
Niegowska J; Sitkiewicz D
Pol Arch Med Wewn; 2004 May; 111(5):547-56. PubMed ID: 15508805
[TBL] [Abstract][Full Text] [Related]
4. The effects of isradipine and spirapril as monotherapy and combined therapy on blood pressure, renal hemodynamics, natriuresis, and urinary kallikrein in hypertensive nephropathy.
Maccariello ER; Genelhu de Abreu Fagundes V; Francischetti EA
Am J Hypertens; 1997 May; 10(5 Pt 1):541-5. PubMed ID: 9160765
[TBL] [Abstract][Full Text] [Related]
5. [The captopril test--an aid in the detection of scarring nephropathy as a cause of arterial hypertension in children].
Peco-Antić A; Nastić-Mirić D; Babić D; Kostić M
Srp Arh Celok Lek; 1999; 127(9-10):305-11. PubMed ID: 10649899
[TBL] [Abstract][Full Text] [Related]
6. Plasma renin activity (PRA) levels and antihypertensive drug use in a large healthcare system.
Sim JJ; Bhandari SK; Shi J; Kalantar-Zadeh K; Rasgon SA; Sealey JE; Laragh JH
Am J Hypertens; 2012 Mar; 25(3):379-88. PubMed ID: 22158065
[TBL] [Abstract][Full Text] [Related]
7. Effect of calcium channel blockade on skin blood flow in diabetic hypertension: a comparison of isradipine and atenolol.
Rendell MS; Shehan MA; Kahler K; Bailey KL; Eckermann AJ
Angiology; 1997 Mar; 48(3):203-13. PubMed ID: 9071195
[TBL] [Abstract][Full Text] [Related]
8. Effects of losartan on the renin-angiotensin-aldosterone axis in essential hypertension.
Bauer IH; Reams GP; Wu Z; Lau-Sieckman A
J Hum Hypertens; 1995 Apr; 9(4):237-43. PubMed ID: 7595905
[TBL] [Abstract][Full Text] [Related]
9. Acute vascular effects of the angiotensin II receptor antagonist olmesartan in normal subjects: relation to the renin-aldosterone system.
Resnick LM; Catanzaro D; Sealey JE; Laragh JH
Am J Hypertens; 2004 Mar; 17(3):203-8. PubMed ID: 15001191
[TBL] [Abstract][Full Text] [Related]
10. A discrepancy between the effects of a single oral dose of captopril on blood pressure, plasma renin activity, and serum angiotensin-converting enzyme levels.
Lechi A; Covi G; Capuzzo MG; Lechi C; Minuz P; Delva P; Scuro LA
Int J Clin Pharmacol Ther Toxicol; 1983 Nov; 21(11):569-74. PubMed ID: 6317579
[TBL] [Abstract][Full Text] [Related]
11. Failure of angiotensin II to suppress plasma renin activity in normotensive subjects with a positive family history of hypertension.
Herlitz H; Palmgren E; Widgren B; Aurell M
Clin Sci (Lond); 2005 Sep; 109(3):311-7. PubMed ID: 15901242
[TBL] [Abstract][Full Text] [Related]
12. Comparative effects of aliskiren-based and ramipril-based therapy on the renin system during long-term (6 months) treatment and withdrawal in patients with hypertension.
Andersen K; Weinberger MH; Constance CM; Ali MA; Jin J; Prescott MF; Keefe DL
J Renin Angiotensin Aldosterone Syst; 2009 Sep; 10(3):157-67. PubMed ID: 19617271
[TBL] [Abstract][Full Text] [Related]
13. Effects of isradipine on hypertension and renal hemodynamics.
Siamopoulos KC; Elisaf M; Dardamanis M; Sferopoulos G; Pappas M
J Cardiovasc Pharmacol; 1992; 19 Suppl 3():S87-9. PubMed ID: 1376846
[TBL] [Abstract][Full Text] [Related]
14. Cardiovascular and renal effects of single administration of three different doses of isradipine in hypertensive patients. Dose-response curves of the different effects.
Rupoli L; Fruscio M; Gradnik R; Chianca R; Leonetti G; Zanchetti A
Am J Med; 1989 Apr; 86(4A):65-6. PubMed ID: 2523658
[TBL] [Abstract][Full Text] [Related]
15. Diagnosis of primary aldosteronism: value of different screening parameters and influence of antihypertensive medication.
Seiler L; Rump LC; Schulte-Mönting J; Slawik M; Borm K; Pavenstädt H; Beuschlein F; Reincke M
Eur J Endocrinol; 2004 Mar; 150(3):329-37. PubMed ID: 15012618
[TBL] [Abstract][Full Text] [Related]
16. Normokalemic hyperaldosteronism in patients with resistant hypertension.
Benchetrit S; Bernheim J; Podjarny E
Isr Med Assoc J; 2002 Jan; 4(1):17-20. PubMed ID: 11802302
[TBL] [Abstract][Full Text] [Related]
17. Low plasma renin activity and high aldosterone/renin ratio are associated with untreated isolated systolic hypertension.
Durukan M; Guray U; Aksu T; Guray Y; Demirkan B; Korkmaz S
Blood Press; 2012 Oct; 21(5):320-5. PubMed ID: 22587638
[TBL] [Abstract][Full Text] [Related]
18. Renal effects of the new calcium channel blocking drug isradipine.
Krämer BK; Häussler M; Ress KM; Müller GA; Burger KJ; Risler T
Eur J Clin Pharmacol; 1990; 39(4):333-5. PubMed ID: 2150190
[TBL] [Abstract][Full Text] [Related]
19. β-Blocker withdrawal is preferable for accurate interpretation of the aldosterone-renin ratio in chronically treated hypertension.
Browne GA; Griffin TP; O'Shea PM; Dennedy MC
Clin Endocrinol (Oxf); 2016 Mar; 84(3):325-31. PubMed ID: 26300226
[TBL] [Abstract][Full Text] [Related]
20. Relationships between sodium clearance, plasma renin activity, plasma aldosterone, renal hemodynamics and blood pressure in essential hypertension.
Reubi FC; Weidmann P
Clin Exp Hypertens (1978); 1980; 2(3-4):593-612. PubMed ID: 7000463
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
